Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the receptor-based interactome of the dopamine D1 receptor: looking for heteromer-selective drugs
Verònica Casadó-Anguera, Antoni Cortés, Vicent Casadó, et al.
Expert Opinion on Drug Discovery (2019) Vol. 14, Iss. 12, pp. 1297-1312
Closed Access | Times Cited: 10

Showing 10 citing articles:

What are the current trends in G protein-coupled receptor targeted drug discovery?
Vicent Casadó, Verònica Casadó-Anguera
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 8, pp. 815-820
Open Access | Times Cited: 15
Heterobivalent Ligand for the Adenosine A2A–Dopamine D2 Receptor Heteromer
Daniel Pulido, Verònica Casadó-Anguera, Marc Gómez‐Autet, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 1, pp. 616-632
Open Access | Times Cited: 19
G Protein–Coupled Receptor Heteromers in Brain: Functional and Therapeutic Importance in Neuropsychiatric Disorders
Yang Sun, Ahmed Hasbi, Susan R. George
The Annual Review of Pharmacology and Toxicology (2025) Vol. 65, Iss. 1, pp. 215-236
Closed Access
Chemical biology of noncanonical G protein–coupled receptor signaling: Toward advanced therapeutics
Maria M. Shchepinova, Aylin C. Hanyaloglu, Gary Frost, et al.
Current Opinion in Chemical Biology (2020) Vol. 56, pp. 98-110
Closed Access | Times Cited: 21
l-DOPA promotes striatal dopamine release through D1 receptors and reversal of dopamine transporter
Riccardo Viaro, Francesco Longo, Fabrizio Vincenzi, et al.
Brain Research (2021) Vol. 1768, pp. 147583-147583
Open Access | Times Cited: 15
Unmasking allosteric-binding sites: novel targets for GPCR drug discovery
Verònica Casadó-Anguera, Vicent Casadó
Expert Opinion on Drug Discovery (2022) Vol. 17, Iss. 8, pp. 897-923
Closed Access | Times Cited: 10
Orally Active Peptide Vector Allows Using Cannabis to Fight Pain While Avoiding Side Effects
Maria Gallo, Estefanía Moreno, Sira Defaus, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 10, pp. 6937-6948
Open Access | Times Cited: 14
How to target membrane proteins for degradation: Bringing GPCRs into the TPD fold
Bogusława Korona, Laura S. Itzhaki
Journal of Biological Chemistry (2024), pp. 107926-107926
Open Access | Times Cited: 1
Heteromerization between α2A adrenoceptors and different polymorphic variants of the dopamine D4 receptor determines pharmacological and functional differences. Implications for impulsive-control disorders
Verònica Casadó-Anguera, Estefanía Moreno, Marta Sánchez‐Soto, et al.
Pharmacological Research (2021) Vol. 170, pp. 105745-105745
Open Access | Times Cited: 6
Estudio de los efectos de la actividad constitutiva del receptor de dopamina tipo 1 (D1R) sobre los canales de calcio operados por voltaje (CaV) y su rol en neuronas de la corteza prefrontal
Clara Inés McCarthy
(2022)
Open Access
Page 1

Scroll to top